As attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archit Organosys Limited announced its audited financial results for the quarter and financial year ended March 31, 2025. Revenue from operations for FY25 stood at Rs. 12,559.92 lacs, up from Rs. 11,319.14 lacs in FY24 (~11% growth). Net profit jumped to Rs. 505.11 lacs from Rs. 333.79 lacs, a rise of about 51%, aided by lower finance costs and no exceptional items this year versus a Rs. 337.27 lacs exceptional gain in the previous year. The Board recommended a final dividend of Rs. 0.50 per equity share (5%) on face value of Rs. 10. The Board also appointed Mr. Ajay P Patel as the new Chief Financial Officer with immediate effect. The statutory auditor (G K Choksi & Co.) issued an unmodified (clean) opinion on the financial results.
Strong profit growth of over 50% YoY and the reinstatement of a dividend are positive signals for shareholders, though the modest dividend yield (~0.5% on a Rs. 10 face value) suggests a conservative payout. Overall the results are shareholder-friendly with no negative auditor remarks.